Summary
Andrew Beam is a technology and research leader who blends 12 years of experience in machine learning, bioinformatics, and product-facing engineering with an academic career at Harvard. As CTO of Lila Sciences and an Associate Professor at Harvard, he builds translational AI systems for biomedical applications while advising startups and industry through roles at Generate:Biomedicines, Flagship Pioneering, and NEJM AI. He cofounded ML teams that moved cutting-edge protein design and biomedicine algorithms toward production, pairing deep technical know-how with experience launching research-driven companies. Trained with a PhD in Bioinformatics and advanced degrees in statistics, computer engineering and electrical engineering from NC State, he navigates both rigorous experimental science and scalable engineering. Colleagues describe him as a bridge between lab and product: he publishes, edits, and helps shape clinical AI discourse while shipping robust ML systems. He often operates at the intersection of academia, venture, and industry—translating scholarly insight into commercially viable, regulatory-aware AI tools.
13 years of coding experience
7 years of employment as a software developer
Doctor of Philosophy - PhD, Doctor of Philosophy - PhD at North Carolina State University